Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.
Yoshino H, Yokoyama S, Tamai M, Okamura S, Iizasa S, Sakaguchi T, Osako Y, Inoguchi S, Matsushita R, Yamada Y, Nakagawa M, Tatarano S, Tanimoto A, Enokida H.
Yoshino H, et al. Among authors: osako y.
FEBS Open Bio. 2023 Jun;13(6):1056-1066. doi: 10.1002/2211-5463.13616. Epub 2023 Apr 29.
FEBS Open Bio. 2023.
PMID: 37079001
Free PMC article.